Efficacy and safety analysis of itopride vs bisacodyl in chronic constipation cases at tertiary care hospital in Prakasam district: A prospective, randomized study

Mohammed Mahaboobbi Zaheera; Thulasi Gokul; Chandrakala Kambar; Jhansi Vani Choppara

doi:10.5455/NJPPP.2024.v14.i12.24

2026, Vol: 16, Issue: 1

16 / 1Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

NJPPP Manuscript Submission Form
Title Page

« Previous Article

Original Research
Online Published: 27 Dec 2024

Natl J Physiol Pharm Pharmacol. 2024; 14(12): 2652-2659

doi: 10.5455/NJPPP.2024.v14.i12.24

Efficacy and safety analysis of itopride vs bisacodyl in chronic constipation cases at tertiary care hospital in Prakasam district: A prospective, randomized study

Mohammed Mahaboobbi Zaheera, Thulasi Gokul, Chandrakala Kambar, Jhansi Vani Choppara.

Abstract
Background:
Chronic functional constipation is a functional bowel disorder characterized by difficult, infrequent, and incomplete defecation, affecting 14% of the world population. The quality of life and health care system are impacted and represents a heavy economic burden. Rome IV criteria are used for the diagnosis of constipation.

Aim:
To compare the safety and efficacy of Itopride vs Bisacodyl in chronic constipation, to evaluate improvement in constipation symptoms using the Validated PAC-SYM questionnaire, to evaluate treatment satisfaction in participants using a 5-point Likert Scale, Bristol Stool Form Score for Stool form assessment.

Methods:
This prospective, randomized study was conducted in Government Medical College, Ongole, for 13 months, with the study population of 150 patients of both genders and aged >18 years. The data analysis is done using the PAC-SYM Score, 5-point Likert Scale, and Bristol Stool Form Scale (BSFS).

Results:
Compared to the bisacodyl group, The mean spontaneous complete bowel movements and spontaneous bowel movements were significantly higher in the itopride group (p < 0.05) at the end of the study. The overall satisfaction levels of patients taking Itopride and Bisacodyl do not significantly differ over time.

Conclusion:
Both drugs appear to have similar satisfaction profiles from baseline to 12 weeks. The BSFS scores differ significantly between Itopride and Bisacodyl during different time intervals. The similar satisfaction profiles suggest that both drugs, Itopride and Bisacodyl can be effectively used to manage constipation, depending on the patient's specific needs and preferences.

Key words: Chronic functional constipation, Bisacodyl, Itopride, Spontaneous bowel movements

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Mohammed Mahaboobbi Zaheera Articles by Thulasi Gokul Articles by Chandrakala Kambar Articles by Jhansi Vani Choppara
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Zaheera MM, Gokul T, Kambar C, Choppara JV. Efficacy and safety analysis of itopride vs bisacodyl in chronic constipation cases at tertiary care hospital in Prakasam district: A prospective, randomized study. Natl J Physiol Pharm Pharmacol. 2024; 14(12): 2652-2659. doi:10.5455/NJPPP.2024.v14.i12.24

Web Style

Zaheera MM, Gokul T, Kambar C, Choppara JV. Efficacy and safety analysis of itopride vs bisacodyl in chronic constipation cases at tertiary care hospital in Prakasam district: A prospective, randomized study. https://www.njppp.com/?mno=225587 [Access: June 26, 2026]. doi:10.5455/NJPPP.2024.v14.i12.24

AMA (American Medical Association) Style

Zaheera MM, Gokul T, Kambar C, Choppara JV. Efficacy and safety analysis of itopride vs bisacodyl in chronic constipation cases at tertiary care hospital in Prakasam district: A prospective, randomized study. Natl J Physiol Pharm Pharmacol. 2024; 14(12): 2652-2659. doi:10.5455/NJPPP.2024.v14.i12.24

Vancouver/ICMJE Style

Zaheera MM, Gokul T, Kambar C, Choppara JV. Efficacy and safety analysis of itopride vs bisacodyl in chronic constipation cases at tertiary care hospital in Prakasam district: A prospective, randomized study. Natl J Physiol Pharm Pharmacol. (2024), [cited June 26, 2026]; 14(12): 2652-2659. doi:10.5455/NJPPP.2024.v14.i12.24

Harvard Style

Zaheera, M. M., Gokul, . T., Kambar, . C. & Choppara, . J. V. (2024) Efficacy and safety analysis of itopride vs bisacodyl in chronic constipation cases at tertiary care hospital in Prakasam district: A prospective, randomized study. Natl J Physiol Pharm Pharmacol, 14 (12), 2652-2659. doi:10.5455/NJPPP.2024.v14.i12.24

Turabian Style

Zaheera, Mohammed Mahaboobbi, Thulasi Gokul, Chandrakala Kambar, and Jhansi Vani Choppara. 2024. Efficacy and safety analysis of itopride vs bisacodyl in chronic constipation cases at tertiary care hospital in Prakasam district: A prospective, randomized study. National Journal of Physiology, Pharmacy and Pharmacology, 14 (12), 2652-2659. doi:10.5455/NJPPP.2024.v14.i12.24

Chicago Style

Zaheera, Mohammed Mahaboobbi, Thulasi Gokul, Chandrakala Kambar, and Jhansi Vani Choppara. "Efficacy and safety analysis of itopride vs bisacodyl in chronic constipation cases at tertiary care hospital in Prakasam district: A prospective, randomized study." National Journal of Physiology, Pharmacy and Pharmacology 14 (2024), 2652-2659. doi:10.5455/NJPPP.2024.v14.i12.24

MLA (The Modern Language Association) Style

Zaheera, Mohammed Mahaboobbi, Thulasi Gokul, Chandrakala Kambar, and Jhansi Vani Choppara. "Efficacy and safety analysis of itopride vs bisacodyl in chronic constipation cases at tertiary care hospital in Prakasam district: A prospective, randomized study." National Journal of Physiology, Pharmacy and Pharmacology 14.12 (2024), 2652-2659. Print. doi:10.5455/NJPPP.2024.v14.i12.24

APA (American Psychological Association) Style

Zaheera, M. M., Gokul, . T., Kambar, . C. & Choppara, . J. V. (2024) Efficacy and safety analysis of itopride vs bisacodyl in chronic constipation cases at tertiary care hospital in Prakasam district: A prospective, randomized study. National Journal of Physiology, Pharmacy and Pharmacology, 14 (12), 2652-2659. doi:10.5455/NJPPP.2024.v14.i12.24

About National Journal of Physiology, Pharmacy and Pharmacology

Contact Information

How to cite this article